nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abnormal brain morphology in MRI scans of first episode schizophrenics associated with poor treatment response
|
Lieberman, J |
|
1990 |
3 |
1 |
p. 19- 1 p. |
artikel |
2 |
Abnormal brain-stem auditory evoked potentials in schizophrenia: Correlations to symptomatology; genetics and csf monoamine metabolite levels
|
Lindstrom, L.H. |
|
1990 |
3 |
1 |
p. 56- 1 p. |
artikel |
3 |
A conceptual model of the schizophrenic syndrome: Implications for psychosocial treatments
|
Sullivan, T |
|
1990 |
3 |
1 |
p. 87- 1 p. |
artikel |
4 |
A decreased influx of tyrosine across the blood-brain barrier in patients with schizophrenia as determined by positron emission tomography
|
Wiesel, F.A. |
|
1990 |
3 |
1 |
p. 26-27 2 p. |
artikel |
5 |
A factor analytic study of ventriculomegaly in schizophrenia: An MRI study
|
Schwarzkopf, SB |
|
1990 |
3 |
1 |
p. 18- 1 p. |
artikel |
6 |
Akathisia variants: Prevalence and iron status in an inpatient population with chronic schizophrenia
|
Barnes, T.R.E. |
|
1990 |
3 |
1 |
p. 79- 1 p. |
artikel |
7 |
A ‘mock-up’ of schizophrenia: Temporal lobe epilepsy and schizophrenia-like psychosis
|
Roberts, G.W. |
|
1990 |
3 |
1 |
p. 94- 1 p. |
artikel |
8 |
An analysis of postmortem brain gene expression in schizophrenic and control subjects
|
Perrett, C.W. |
|
1990 |
3 |
1 |
p. 15-16 2 p. |
artikel |
9 |
An autoradiographic study in schizophrenia: Evidence for an altered laminar distribution of 3H-d-aspartate binding in orbito-frontal cortex
|
Royston, M.C. |
|
1990 |
3 |
1 |
p. 31-32 2 p. |
artikel |
10 |
An open trial of ondansetron (GR38032F) in the treatment of acute schizophrenia
|
Williams, P. |
|
1990 |
3 |
1 |
p. 48- 1 p. |
artikel |
11 |
Apomorphine effects on brain metabolism in neuroleptic naive first episode schizophrenics and normal controls
|
Cleghorn, J.M. |
|
1990 |
3 |
1 |
p. 25- 1 p. |
artikel |
12 |
A prospective study of the interaction between life events and neuroleptic medication on the course of schizophrenic symptoms
|
Cramer, P. |
|
1990 |
3 |
1 |
p. 11- 1 p. |
artikel |
13 |
A study of the social environment and clinical poverty in long stay chronic schizophrenic patients in a British Mental Hospital in 1988: A reassessment of institutionalism and schizophrenia
|
Curson, D. |
|
1990 |
3 |
1 |
p. 7- 1 p. |
artikel |
14 |
Auditory evoked potentials in chronic schizophrenics
|
Eikelmann, B. |
|
1990 |
3 |
1 |
p. 57- 1 p. |
artikel |
15 |
Author index
|
|
|
1990 |
3 |
1 |
p. 95- 1 p. |
artikel |
16 |
Behavior therapy with chronic schizophrenic patients: Special effects of a ‘cognitive’ and ‘social skills’ training program
|
Hubmann, W |
|
1990 |
3 |
1 |
p. 87-88 2 p. |
artikel |
17 |
Beta-blockers in schizophrenia: A review of the literature
|
Ratey, J. |
|
1990 |
3 |
1 |
p. 49- 1 p. |
artikel |
18 |
Biochemical pharmacology of the atypical neuroleptic remoxipride
|
Kohler, C. |
|
1990 |
3 |
1 |
p. 44-45 2 p. |
artikel |
19 |
Brain morphology in first episode cases of schizophrenia
|
DeLisi, L.E. |
|
1990 |
3 |
1 |
p. 20- 1 p. |
artikel |
20 |
Calcitonin gene-related pedtide in the amygdaloid complex of the rat: Immunohistochemical and quantitative distribution, and drug effects on calcium-dependent, potassium-evokedin vitro release
|
Saria, A. |
|
1990 |
3 |
1 |
p. 35- 1 p. |
artikel |
21 |
Can a neurodevelopmental framework provide an explanation for heterogeneity in schizophrenia?
|
Murray, R.M. |
|
1990 |
3 |
1 |
p. 17- 1 p. |
artikel |
22 |
Carbamazepine in chronic schizophrenic patients: Adjunct of carbamazepine to neuroleptic therapy
|
Meszaros, K. |
|
1990 |
3 |
1 |
p. 50- 1 p. |
artikel |
23 |
Catatonia as a life threatening disease at the intensive psychiatric care unit
|
Basny, Z |
|
1990 |
3 |
1 |
p. 73- 1 p. |
artikel |
24 |
Cerebral metabolic changes as a consequence of DA receptor blockade
|
Tamminga, C.A. |
|
1990 |
3 |
1 |
p. 25- 1 p. |
artikel |
25 |
Cerebral spect in drug free schizophrenic patients
|
Vita, A |
|
1990 |
3 |
1 |
p. 24- 1 p. |
artikel |
26 |
Characteristics of ‘normal’ controls who volunteer for schizophrenia research
|
Olson, S.C. |
|
1990 |
3 |
1 |
p. 92- 1 p. |
artikel |
27 |
Clinical and cognitive correlates of occulomotor abnormalities in schizophrenia
|
Thaker, G. |
|
1990 |
3 |
1 |
p. 60- 1 p. |
artikel |
28 |
Codetermination of medication as a step towards improved compliance: The patient's viewpoint
|
|
|
1990 |
3 |
1 |
p. 41- 1 p. |
artikel |
29 |
Cognitive and social treatment for chronic schizophrenic patients
|
Merlo, M.C.G. |
|
1990 |
3 |
1 |
p. 88- 1 p. |
artikel |
30 |
Cognitive functioning and symptomatology in chronic schizophrenia
|
Nelson, H.E. |
|
1990 |
3 |
1 |
p. 63-64 2 p. |
artikel |
31 |
Collaborative patient and staff treatment planning groups: Recognition of the limits and goals of treatment
|
McCarthy, R.H. |
|
1990 |
3 |
1 |
p. 86-87 2 p. |
artikel |
32 |
Combined serotonin 5-HT2 and dopamine D2 receptor antagonism in the treatment of schizophrenia
|
Heylen, S.L.E. |
|
1990 |
3 |
1 |
p. 46-47 2 p. |
artikel |
33 |
Comparison of spiperone binding to lymphocytes in schizophrenics, their first degree relatives and control subjects
|
Griffiths, R.S. |
|
1990 |
3 |
1 |
p. 31- 1 p. |
artikel |
34 |
CT abnormalities in early stage of schizophrenics
|
Ohtani, Tsuyoshi |
|
1990 |
3 |
1 |
p. 19- 1 p. |
artikel |
35 |
Current opinion about atypical compounds in schizophrenia
|
Verhoeven, W.M.A. |
|
1990 |
3 |
1 |
p. 41- 1 p. |
artikel |
36 |
D1- and D2-dopamine receptor occupancy during treatment with classical and atypical neurpleptics
|
Farde, L. |
|
1990 |
3 |
1 |
p. 51-52 2 p. |
artikel |
37 |
Decreased in vitro tyrosine transport in schizophrenic patients
|
Bjerkenstedt, L. |
|
1990 |
3 |
1 |
p. 38- 1 p. |
artikel |
38 |
Deficit and non-deficit schizophrenia: Sleep, occulomotor amd MRI studies
|
Gerbaldo, H. |
|
1990 |
3 |
1 |
p. 60- 1 p. |
artikel |
39 |
Different profile of the neuroleptic induced upregulation of the dopaminergic d2 receptors in nigrostriatal and mesolimbic systems
|
Laruelle, M |
|
1990 |
3 |
1 |
p. 29-30 2 p. |
artikel |
40 |
Different semantic information processing in schizophrenics
|
Volz, H.-P. |
|
1990 |
3 |
1 |
p. 55-56 2 p. |
artikel |
41 |
Differing time course of emergence of psychotic symptoms and dyskinesia after neuroleptic withdrawal
|
Dixon, L |
|
1990 |
3 |
1 |
p. 78-79 2 p. |
artikel |
42 |
Distributed brain glutamate and GABA mechanisms in schizophrenia
|
Deakin, J.F.W. |
|
1990 |
3 |
1 |
p. 33- 1 p. |
artikel |
43 |
Do neuroleptic drugs affect the accesibility of the CNS to exogenous psychoactive substances?
|
Ramchand, C.N. |
|
1990 |
3 |
1 |
p. 51- 1 p. |
artikel |
44 |
Dopamine receptor sensitivity and tardive-dyskinesia
|
Yadalam, K.G. |
|
1990 |
3 |
1 |
p. 80- 1 p. |
artikel |
45 |
Dopaminergic behavioral hypersensitivity in monkeys receiving long term neuroleptic treatment
|
Casey, D.E. |
|
1990 |
3 |
1 |
p. 79-80 2 p. |
artikel |
46 |
Editorial
|
DeLisi, Lynn E. |
|
1990 |
3 |
1 |
p. 3-4 2 p. |
artikel |
47 |
Editorial Board
|
|
|
1990 |
3 |
1 |
p. IFC- 1 p. |
artikel |
48 |
EEG brain mapping in schizophrenia and depression: Psychophyysiology as a maker for diagnosis and state
|
Gallhofer, B. |
|
1990 |
3 |
1 |
p. 53- 1 p. |
artikel |
49 |
EEG power spectral components of schizoaffective disorders
|
Schellenberg, R. |
|
1990 |
3 |
1 |
p. 54- 1 p. |
artikel |
50 |
Effect of chronic neuroleptic treatment on spontaneously active dopamine neurones in the A9 and A10 area of rat brain: Correlation to receptor profile?
|
Hyttel, J. |
|
1990 |
3 |
1 |
p. 50-51 2 p. |
artikel |
51 |
Effects of partial dopamine receptor agonists on the d-amphetamine discriminative cue
|
Clark, D |
|
1990 |
3 |
1 |
p. 84-85 2 p. |
artikel |
52 |
Elevated d2 receptor density in 23 schizophrenics
|
Tune, L.E. |
|
1990 |
3 |
1 |
p. 29- 1 p. |
artikel |
53 |
Ergopsychometry—Results of a stress load program in schizophrenics
|
Gunther, V |
|
1990 |
3 |
1 |
p. 68-69 2 p. |
artikel |
54 |
Evidence for independent transmission of genetic vulnerability and age of onset in schizophrenia
|
Taylor, C. |
|
1990 |
3 |
1 |
p. 13- 1 p. |
artikel |
55 |
Eye movement abnormality in schizoptypal personality disorder (SPD)
|
Thaker, G. |
|
1990 |
3 |
1 |
p. 59- 1 p. |
artikel |
56 |
Family history, obstetric complications and age at onset of schizophrenia: A case control study
|
Jones, P.B. |
|
1990 |
3 |
1 |
p. 8- 1 p. |
artikel |
57 |
Family studies in schizophrenia and affective disorders: Evidence for a continuum model
|
Maier, W. |
|
1990 |
3 |
1 |
p. 12-13 2 p. |
artikel |
58 |
Free radical involvement in schizophrenia and tardive dyskinesia
|
Shriqui, C.L. |
|
1990 |
3 |
1 |
p. 81- 1 p. |
artikel |
59 |
Free radicals, neuroleptic drugs and tardive dyskinesia
|
Medley, I |
|
1990 |
3 |
1 |
p. 81-82 2 p. |
artikel |
60 |
Gender differences in age-of-onset of schizophrenia and manic-depressive disease
|
Papezova, H. |
|
1990 |
3 |
1 |
p. 8-9 2 p. |
artikel |
61 |
Human data on an animal model of schizophrenia
|
Lubow, R.E. |
|
1990 |
3 |
1 |
p. 69-70 2 p. |
artikel |
62 |
ICI 204,636: A new and novel atypical antipsychotic drug
|
Malick, J.B. |
|
1990 |
3 |
1 |
p. 46- 1 p. |
artikel |
63 |
Indexing CNS receptor in schizophrencs by jointly assessing psychophysiological and catecholaminergic activity
|
Olbrich, R. |
|
1990 |
3 |
1 |
p. 58- 1 p. |
artikel |
64 |
Information processing in schizophrenai
|
Weller, M.P. |
|
1990 |
3 |
1 |
p. 61- 1 p. |
artikel |
65 |
Is low-EE a synonym for a protective familiar atmosphere in schizophrenia?
|
Schulze-Monking, H |
|
1990 |
3 |
1 |
p. 76-77 2 p. |
artikel |
66 |
Kinetics of oral clozapine
|
Haring, C. |
|
1990 |
3 |
1 |
p. 42- 1 p. |
artikel |
67 |
Lateralized symptomatology in schizophrenia: Anomalous visual experiences and body image disorders
|
Cutting, J |
|
1990 |
3 |
1 |
p. 74- 1 p. |
artikel |
68 |
Learning to live with schizophrenia: A new residential facility as an example for an emerging paradigm
|
Katschnig, H |
|
1990 |
3 |
1 |
p. 92-93 2 p. |
artikel |
69 |
Long-term treatment of chronic schizophrenia patients with risperidone
|
Mertens, C. |
|
1990 |
3 |
1 |
p. 48- 1 p. |
artikel |
70 |
Maine's replication of vermont's 32 years outcome study: Recent findings and surprising implications
|
Harding, C.M. |
|
1990 |
3 |
1 |
p. 9-10 2 p. |
artikel |
71 |
Maintenance treatment in schizophrenia: Current status in Austria
|
Meise, U. |
|
1990 |
3 |
1 |
p. 39- 1 p. |
artikel |
72 |
Mechanisms underlying abnormalities in verbal fluency in schizophrenia
|
Allen, H |
|
1990 |
3 |
1 |
p. 67-68 2 p. |
artikel |
73 |
Memory dysfunction in schizophrenia
|
McKenna, P.J. |
|
1990 |
3 |
1 |
p. 67- 1 p. |
artikel |
74 |
Mental effort in psychotic patients
|
Schamand, B. |
|
1990 |
3 |
1 |
p. 64- 1 p. |
artikel |
75 |
Mental effort in psychotic patients
|
Kuipers, T |
|
1990 |
3 |
1 |
p. 68- 1 p. |
artikel |
76 |
Minor sensoric and motoric disturbances (Neurological soft-signs) in remitting and chronic schizophrenia
|
Schröder, J |
|
1990 |
3 |
1 |
p. 93-94 2 p. |
artikel |
77 |
Modality-dependent post-imperative negative variations in schizophrenic patients
|
Cohen, R |
|
1990 |
3 |
1 |
p. 69- 1 p. |
artikel |
78 |
Nadolol treat aggression and psychiatric symptomatology in chronic psychiatric inpatients
|
Ratey, J. |
|
1990 |
3 |
1 |
p. 49- 1 p. |
artikel |
79 |
Neurochemical pathology in schizopherinia: Limbic deficits in GABA systems
|
Reynolds, G.P. |
|
1990 |
3 |
1 |
p. 34- 1 p. |
artikel |
80 |
Neuroleptic drug effects on cognitive function in schizophrenia
|
Cleghorn, J.M. |
|
1990 |
3 |
1 |
p. 64-65 2 p. |
artikel |
81 |
Neuropsychological indicators for the vulnerability to schizophrenia
|
Maier, W. |
|
1990 |
3 |
1 |
p. 62- 1 p. |
artikel |
82 |
Non-organic psychoses amongst Asian immigrants and English-born controls: A comparison of service utilization
|
Gupta, S. |
|
1990 |
3 |
1 |
p. 9- 1 p. |
artikel |
83 |
On the pathogenetic role of dopaminergic and serotonergic neurotransmission in longterm hospitalized psychotic patients
|
Louwerens, J.W. |
|
1990 |
3 |
1 |
p. 52- 1 p. |
artikel |
84 |
On the positive - negative distinction of schizophrenia: C orrelations between psychopathology and EEG brain mapping
|
Kufferle, B. |
|
1990 |
3 |
1 |
p. 53-54 2 p. |
artikel |
85 |
Ordering thoughts on thought disorder
|
McGrath, J |
|
1990 |
3 |
1 |
p. 73- 1 p. |
artikel |
86 |
P300 and eye movement disorder used as physiological markers in linkage studies in schizophrenia
|
Blackwood, D.H.R. |
|
1990 |
3 |
1 |
p. 55- 1 p. |
artikel |
87 |
P300 and processing negativity in schizophrenic illness: trait or state markers?
|
Ward, P.B. |
|
1990 |
3 |
1 |
p. 54-55 2 p. |
artikel |
88 |
Patients' reactions to psychoeducation and untoward effects
|
van Meer, C.R. |
|
1990 |
3 |
1 |
p. 88- 1 p. |
artikel |
89 |
Patterns of negative symptoms
|
Kuipers, T |
|
1990 |
3 |
1 |
p. 72- 1 p. |
artikel |
90 |
Patterns of schizophrenia in British Caribbeans
|
Glover, G.R. |
|
1990 |
3 |
1 |
p. 6-7 2 p. |
artikel |
91 |
Phencyclidine and sigma receptor abnormalities in schizophrenic post mortem brain
|
|
|
1990 |
3 |
1 |
p. 32- 1 p. |
artikel |
92 |
Photophobic and photomanic behavior in psychoses
|
Gerbaldo, H |
|
1990 |
3 |
1 |
p. 74-75 2 p. |
artikel |
93 |
Physical anomalies and neurodevelopmental abnormality in schizophrenia: New clinical correlates
|
Waddington, J.L. |
|
1990 |
3 |
1 |
p. 90- 1 p. |
artikel |
94 |
Physical Mapping of the schizophrenia-superconductivity locus (SCZI) on chromosome 5 using pulsed field gel electrophoresis
|
Mankoo, B.S. |
|
1990 |
3 |
1 |
p. 15- 1 p. |
artikel |
95 |
Plasma IgA antibodies against casein and other food antigens in schizophrenic patients and normal controls
|
Lindstrom, L.H. |
|
1990 |
3 |
1 |
p. 35-36 2 p. |
artikel |
96 |
Plasma polyamine oxidase in normal and schizophrenic subjects
|
Das, I. |
|
1990 |
3 |
1 |
p. 37-38 2 p. |
artikel |
97 |
Platelet model of abnormal signal transduction in schizophrenia
|
Kaiya, H. |
|
1990 |
3 |
1 |
p. 36- 1 p. |
artikel |
98 |
Positive and negative symptoms in chronic schizophrenia: A 1-year follow-up study
|
Cazzullo, C.L. |
|
1990 |
3 |
1 |
p. 72- 1 p. |
artikel |
99 |
Positron emission tomography and psychometry in schizophrenia
|
Hashimoto, T |
|
1990 |
3 |
1 |
p. 26- 1 p. |
artikel |
100 |
Post dose reduction survival in the maintenance treatment of schizophrenia
|
Heresco-Levy, U. |
|
1990 |
3 |
1 |
p. 39-40 2 p. |
artikel |
101 |
Post-mortem neurochemical studies of tardive dyskinesia
|
Reynolds, G.P. |
|
1990 |
3 |
1 |
p. 82-83 2 p. |
artikel |
102 |
Postmortem study of the dopaminergic d1 receptors in the dorsolateral prefrontal cortex of schizophrenics and controls
|
Laurelle, M |
|
1990 |
3 |
1 |
p. 30-31 2 p. |
artikel |
103 |
Predicting relapse of schizophrenic patients on the basis of camberwell family interview and gottschalk-gleser ratings: A failure to replicate
|
Niedermeier, T |
|
1990 |
3 |
1 |
p. 76- 1 p. |
artikel |
104 |
Predictors of outcome in chronic schizophrenia
|
Azzone, P. |
|
1990 |
3 |
1 |
p. 10- 1 p. |
artikel |
105 |
Pregnancy and birth complications as causes of psychiatric illness in adult life: A study utilizing the perinatal mortality survey (1958)
|
Done, J |
|
1990 |
3 |
1 |
p. 91- 1 p. |
artikel |
106 |
Preliminary findings in search of a genetic linkage of schizophrenia to a locus on chromosome 5
|
O'Neil, F.A. |
|
1990 |
3 |
1 |
p. 14- 1 p. |
artikel |
107 |
Psychosis associated with demonstrable disease of the CNS
|
Feinstein, A |
|
1990 |
3 |
1 |
p. 89-90 2 p. |
artikel |
108 |
Putamen metabolic activity predicts dyskinesia severity in schizophrenic patients
|
Holcomb, H.H. |
|
1990 |
3 |
1 |
p. 82- 1 p. |
artikel |
109 |
Reduced cerebral volume in schizophrenia
|
Nasrallah, H.A. |
|
1990 |
3 |
1 |
p. 17- 1 p. |
artikel |
110 |
Reduced frontal area and poorer frontal functioning in schzophrenics: An MRI, neuropsychological and psychophysiological examination
|
Raine, A |
|
1990 |
3 |
1 |
p. 21- 1 p. |
artikel |
111 |
Reduced temporal lobe areas in schizophrenia: Preliminary evidences from a controlled multiplanar magnetic resonance study
|
Rossi, A |
|
1990 |
3 |
1 |
p. 21-22 2 p. |
artikel |
112 |
Regional cerebral metabolic activity in chronic schizophrenia
|
Liddle, P.F. |
|
1990 |
3 |
1 |
p. 23-24 2 p. |
artikel |
113 |
Regulation of the platelet polyphosphoinositide system by antipsychotic drugs: A specific neuroleptic action
|
Essali, M.A. |
|
1990 |
3 |
1 |
p. 36-37 2 p. |
artikel |
114 |
Rehabilitation-project assen-groningen: Cognitive dysfunction and social skills
|
Apelo, M |
|
1990 |
3 |
1 |
p. 66-67 2 p. |
artikel |
115 |
Relationship between premorbid characteristics, symptomatology and coping in first onset schizophrenics
|
Thurm-Mussgay, I |
|
1990 |
3 |
1 |
p. 71- 1 p. |
artikel |
116 |
Remoxipride — A selective dopamine D2 antagonist in the treatment of acute schizophrenia: a Canadian multicentre clinical trial
|
Awad, A.G. |
|
1990 |
3 |
1 |
p. 45- 1 p. |
artikel |
117 |
Remoxipride: Overview of results from a clinical evaluation programme in schizophrenia
|
Lewander, T. |
|
1990 |
3 |
1 |
p. 45-46 2 p. |
artikel |
118 |
Remoxipride versus haloperidol in the treatment of acute schizophrenia: The incidence and severity of extrapyramidal symptoms
|
Morrison, D. |
|
1990 |
3 |
1 |
p. 43- 1 p. |
artikel |
119 |
Right hemisphere function in schizoprenia and magic depression
|
David, A.S. |
|
1990 |
3 |
1 |
p. 74- 1 p. |
artikel |
120 |
Ritanserin in the treatment of neuroleptic-induced akathesia
|
Fleischhacker, W.W. |
|
1990 |
3 |
1 |
p. 47- 1 p. |
artikel |
121 |
Schizophrenia clusters in the north of Scotland from 1900–1960
|
Kerridge, D. |
|
1990 |
3 |
1 |
p. 5- 1 p. |
artikel |
122 |
Search for cytomegalovirus in the post-mortem brains of schizophrenic patients using the polymerase chain reaction
|
Alexander, R.C. |
|
1990 |
3 |
1 |
p. 89- 1 p. |
artikel |
123 |
Selective dopamine D2 antagonist, remoxipride,in the treatment of acute schizophrenia - results of proclactin studies
|
Awad, A.G. |
|
1990 |
3 |
1 |
p. 43- 1 p. |
artikel |
124 |
Siblings of schizophrenia probands: Presence of neuropsychological impairments
|
Pogue-Geile, M. |
|
1990 |
3 |
1 |
p. 62- 1 p. |
artikel |
125 |
Significance of possitive and negative symptoms in chronic schizophrenics patients
|
Maylath, E |
|
1990 |
3 |
1 |
p. 71- 1 p. |
artikel |
126 |
Social behavior and cognitive function in chronic schizophrenia
|
Liddle, P |
|
1990 |
3 |
1 |
p. 65-66 2 p. |
artikel |
127 |
Somatosensory evoked potentials and sensorimotor processing in schizophrenic symptom types
|
Davies, W.T. |
|
1990 |
3 |
1 |
p. 57-58 2 p. |
artikel |
128 |
Some aspects of cognitive function in schizophrenia
|
Landro, N.I. |
|
1990 |
3 |
1 |
p. 63- 1 p. |
artikel |
129 |
Structural and functional characteristics of the corpus callosum in schzophrenics, psychiatric controls, and normal controls: An MRI and neuropsychological evaluation
|
Raine, A |
|
1990 |
3 |
1 |
p. 20- 1 p. |
artikel |
130 |
Studies on the mechanism(s) for the ‘atypical’ neuroleptic activity of remoxipride
|
Ogren, S.O. |
|
1990 |
3 |
1 |
p. 44- 1 p. |
artikel |
131 |
Study of monozygotic twins with psychosis
|
Torrey, E.F. |
|
1990 |
3 |
1 |
p. 90-91 2 p. |
artikel |
132 |
Subjective experience and response to clozapine
|
Grimaldi, J. |
|
1990 |
3 |
1 |
p. 42- 1 p. |
artikel |
133 |
Substance abuse and schizophrenia: Effects on symptoms but not on neurocognitive function
|
Cleghorn, J.M. |
|
1990 |
3 |
1 |
p. 65- 1 p. |
artikel |
134 |
Superior temporal gyrus volume in schizophrenia
|
Barta, P.E. |
|
1990 |
3 |
1 |
p. 22- 1 p. |
artikel |
135 |
Tardive dyskinesia and cognitive functions in schizophrenia
|
Soni, S.D. |
|
1990 |
3 |
1 |
p. 78- 1 p. |
artikel |
136 |
Tardive dyskinesia: Outcome at 10 years
|
Casey, D.E. |
|
1990 |
3 |
1 |
p. 11- 1 p. |
artikel |
137 |
The effects of alpha-tocopherol in schizophrenic patients treated with neuroleptics
|
Fojtikova, I |
|
1990 |
3 |
1 |
p. 93- 1 p. |
artikel |
138 |
The effects of dopamine agonests on CBF (133XE dynamic spect) and negative symptoms in schizophrenia
|
Daniel, D.G. |
|
1990 |
3 |
1 |
p. 28- 1 p. |
artikel |
139 |
The effects of neuroleptics on CBF and CMRO2 in schizophrenic patients: A study using pet
|
Macda, T |
|
1990 |
3 |
1 |
p. 26- 1 p. |
artikel |
140 |
The electrodermal orienting response in schizophrenics and its stability across different clinical states
|
Mussgay, L. |
|
1990 |
3 |
1 |
p. 59- 1 p. |
artikel |
141 |
The glutaminergic hypothesis of schizophrenia: A study using positron emission tomography
|
Kishimoto, H |
|
1990 |
3 |
1 |
p. 27- 1 p. |
artikel |
142 |
The influence of expressed emotion on autonomic and behavioral measures of schizophrenic patients and their relatives
|
Schlenker, R |
|
1990 |
3 |
1 |
p. 76- 1 p. |
artikel |
143 |
The natural history of schizotypal features and disorder
|
Squires-Wheeler, E. |
|
1990 |
3 |
1 |
p. 13-14 2 p. |
artikel |
144 |
The neurochemical anatomy of the hippocampus in post-mortem schizophrenic brain
|
Kerwin, R. |
|
1990 |
3 |
1 |
p. 33-34 2 p. |
artikel |
145 |
The premorbid adjustment of offendant and non-offendant schizophrenics
|
Foldes, P. |
|
1990 |
3 |
1 |
p. 75- 1 p. |
artikel |
146 |
The results of training of perceptual and cognitive functions with chronic schizophrenic patients
|
Van der Gaag, M |
|
1990 |
3 |
1 |
p. 66- 1 p. |
artikel |
147 |
The schizophrenias: Diseases in the basal ganglia or in the cortex? A study using pet
|
Abe, H |
|
1990 |
3 |
1 |
p. 27-28 2 p. |
artikel |
148 |
The South and North Camden schizophrenia surveys: The prevalence of schizophrenia by electoral ward and its relationship to social demographic factors
|
Pantelis, C. |
|
1990 |
3 |
1 |
p. 6- 1 p. |
artikel |
149 |
The validity of the ICD-10- and DSM-III-R-classification of psychotic disorders by family study data
|
Mainer, W. |
|
1990 |
3 |
1 |
p. 12- 1 p. |
artikel |
150 |
Three dimensional registration, display, and analysis of PET-MR images
|
Holcomb, H.H. |
|
1990 |
3 |
1 |
p. 23- 1 p. |
artikel |
151 |
Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenia outpatients: Clinical and social outcome at 2 years
|
Hirsch, S.R. |
|
1990 |
3 |
1 |
p. 40- 1 p. |
artikel |
152 |
Usefulness of an animal psychosis model
|
Franzen, U |
|
1990 |
3 |
1 |
p. 84- 1 p. |
artikel |
153 |
Ventricular system morphology in first episode schizophrenia: A volumetric study of ventricular subdivisions on MRI
|
Degreef, G |
|
1990 |
3 |
1 |
p. 18- 1 p. |
artikel |
154 |
White matter T1 times in schizophrenic patients and healthy controls on MRI scan
|
Harvey, I |
|
1990 |
3 |
1 |
p. 22- 1 p. |
artikel |
155 |
Why is schizophrenia disappearing?
|
Murray, R.M. |
|
1990 |
3 |
1 |
p. 5- 1 p. |
artikel |